Ticker
AYTUCompany Name
AYTU BIOPHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 124.18M | $ 42.2M | 33.98% |
3/31/2025 | $ 124.2M | $ 48.71M | 39.22% |
12/31/2024 | $ 116.23M | $ 49.96M | 42.98% |
9/30/2024 | $ 115.83M | $ 51.2M | 44.21% |
6/30/2024 | $ 118.09M | $ 52.45M | 44.42% |
3/31/2024 | $ 128.86M | $ 54.08M | 41.97% |
12/31/2023 | $ 131.25M | $ 55.71M | 42.45% |
9/30/2023 | $ 132.89M | $ 57.34M | 43.15% |
6/30/2023 | $ 136.46M | $ 58.97M | 43.21% |
3/31/2023 | $ 147.22M | $ 63.46M | 43.11% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for AYTU BIOPHARMA INC is calculated as follows: Intangibles [ $ 75.37M ] / Assets [ $ 141.27M ]
(=) Intang. to Assets [ 53.35% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.23K |
---|---|
min | 0% |
max | 23.1% |
average | 3.98% |
median | 0.51% |
std | 6.08% |